Leuprorelin 53714-56-0
| Systematic (IUPAC) name: |
N-[1-[[1-[[1-[[1-[[1-[[1-[[5-(diaminomethylideneamino)-1-[2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxo-pentan-2-yl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]-2-(4-hydroxyphenyl)ethyl]carbamoyl]-2-hydroxy-ethyl]carbamoyl]-2-(1H-indol-3-yl)ethyl]carbamoyl]-2-(3H-imidazol-4-yl)ethyl]-5-oxo-pyrrolidine-2-carboxamide |
| Leuprorelin CAS number: |
53714-56-0 |
| ATC code: |
L02AE02 |
| PubChem: |
441410 |
| DrugBank: |
DB00007 |
| Formula: |
C59H84N16O12 |
| Molecular mass: |
1209.4 [[Gram g/mol |
| Leuprorelin Assay/Purity: |
Typically NLT 98% |
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.
